PURE Bioscience, Inc. Convertible Notes Payable, Current
PURE Bioscience, Inc. (PURE) had Convertible Notes Payable, Current of $2.75 million as of 2026-04-30, per its 10-Q filed 2026-06-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-06-15
- 2026-04-30: Convertible Notes Payable, Current $2.75M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2026-04-30 | $2.75M 10-Q · filed 2026-06-15 |